Nobel Biocare sees profits slump

Swiss dental implant maker Nobel Biocare lost more ground to rival Straumann in the fourth quarter and added a slump in profit to the woes that ended finance chief Domenico Scala’s tenure 24 hours ago. The group, which has announced former Nestle executive Richard Laube as its new boss, posted an 80 per cent tumble in fourth-quarter net profit to €5.2m (£4.4m), with patients reluctant to spend on pricier products and non-urgent treatments. Sales dipped 1.6 per cent to €153.2m despite a boost from the euro’s weakness, missing analysts’ expectations.